The Neuroregeneration group (NRG), led by Prof Joost Verhaagen, aims to develop gene therapy to repair nerve damage in the central nervous system (CNS) and the Neuroimmunology Research (IMM) group, led by Prof Inge Huitinga, studies the molecular and cellular factors underlying the pathology of multiple sclerosis (MS).